EcoDrugPlus

Glutaminase

Ensembl ID : ENSEEEG00000023376
Gene Symbol: GLS
4 Cross references
174 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSEEEG00000012646
Gene Symbol: GLSA
2 Cross references
231 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSEEEG00000022676
Gene Symbol: GSTP1
4 Cross references
161 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSEEEG00000003793
Gene Symbol: GSK3AB
4 Cross references
140 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSEEEG00000019444
Gene Symbol: GSK3BA
4 Cross references
207 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSEEEG00000022028
Gene Symbol: LOC113578689
4 Cross references
174 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSEEEG00000015315
Gene Symbol: LOC113571197
3 Cross references
191 Possible Orthologues:

Granzyme H

Ensembl ID : ENSEEEG00000022468
Gene Symbol: SI:CH211-212D10.1
3 Cross references
1128 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSEEEG00000001307
Gene Symbol: GHRHR
4 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSEEEG00000020014
Gene Symbol: GHSR
4 Cross references
200 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSEEEG00000005116
Gene Symbol: GHSRA
4 Cross references
196 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSEEEG00000004735
Gene Symbol: GUCY1A1
4 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).